Pfizer recently announced that it has acquired Amplyx Pharmaceuticals to expand its anti-infective therapies pipeline.
Amplyx’s lead compound, Fosmanogepix, is a novel investigational...
Hologic, a global leader in women’s health, recently signed a $795 million definitive agreement to acquire Mobidiag Oy, a commercial stage developer of innovative molecular...
The Federal Trade Commission (FTC) recently filed an administrative complaint and authorized a federal court lawsuit to block Illumina’s $7.1 million pharma acquisition deal of cancer detection...
The Federal Trade Commission (FTC) recently launched a working group to update its approach to analyzing the effects of pharmaceutical mergers and acquisitions.
The joint project will adopt...
Amgen has acquired Five Prime Therapeutics in a $1.9 billion pharma acquisition deal to advance its immuno-oncology and targeted cancer therapies portfolio.
The acquisition adds Five...
Eli Lilly & Company recently announced that it will acquire Prevail Therapeutics in an $800 million pharmaceutical acquisition deal.
The acquisition agreement will establish a new modality for...
AstraZeneca recently acquired Boston-based rare disease specialist, Alexion Pharmaceuticals, in a $39 billion pharmaceutical acquisition deal.
Notably, the deal will be AstraZeneca’s...
Merck recently signed a $2.75 billion pharmaceutical acquisition deal to purchase all outstanding shares of VelosBio, subject to certain customary adjustments.
Clinical-stage biopharmaceutical...
Bayer recently announced a $4 billion pharma acquisition deal with Asklepios BioPharmaceutical (AskBio) to broaden its base in cell and gene therapy.
As part of the acquisition deal, Bayer...
Johnson & Johnson recently announced the completion of a $6.5 billion pharmaceutical acquisition deal involving biotechnology company Momenta Pharmaceuticals, Inc.
This announcement comes a...
The COVID-19 pandemic has substantially shaped the pharmaceutical and biopharmaceutical industry over the first half of 2020, and while some of the activity was predictable, other trends have surprised...
Johnson & Johnson recently announced that it signed a $6.5 billion pharma acquisition deal with Momenta Pharmaceuticals Inc., a company that discovers novel therapies for immune-mediated...
Sanofi recently announced that it will acquire biopharmaceutical company, Principia Biopharma Inc, in a pharma acquisition deal of $100 per share in cash.
Principia Biopharma focuses on developing...
Bristol Myers Squibb recently announced it acquired Dragonfly Therapeutics’ investigational immunotherapy program for $475 million.
Under the definitive agreement, Bristol Myers Squibb will be...
A recent PwC insights analysis found that the pharmaceutical merger and acquisition activity saw a notable decline in the first half of 2020, but the potential for consolidation in specific sub-sectors...
Gilead Sciences recently announced that it will acquire 49.9 percent equity interest in Pionyr Immunotherapeutics Inc with exclusive option for $275 million.
Pionyr, a privately held company...
